Currency In USD
| Previous Close | 5.66 |
| Open | 5.74 |
| Day High | 5.96 |
| Day Low | 5.65 |
| 52-Week High | 14.91 |
| 52-Week Low | 2.77 |
| Volume | 1.05M |
| Average Volume | 1.42M |
| Market Cap | 343.51M |
| PE | 2.23 |
| EPS | 2.6 |
| Moving Average 50 Days | 4.85 |
| Moving Average 200 Days | 7.08 |
| Change | 0.13 |
embecta names new Chairman of the Board and Lead Independent Director
GlobeNewswire Inc.
Feb 11, 2026 9:10 PM GMT
PARSIPPANY, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that the Boar
Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results
GlobeNewswire Inc.
Feb 05, 2026 11:30 AM GMT
PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported first quarter
embecta to Report Fiscal First Quarter Financial Results
GlobeNewswire Inc.
Jan 22, 2026 10:00 PM GMT
PARSIPPANY, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call t